David T. Jones (biochemist)

[citation needed] Jones was educated at Imperial College London where he was awarded a Bachelor of Science degree in Physics.[when?

][citation needed] He moved to King's College London to complete a Master of Science degree in Biochemistry[when?]

[5] He has consulted for a few different companies, including GlaxoSmithKline, but his main industry experience was as a co-founder of Inpharmatica Limited,[2] which was founded in 1998 as a corporate spin-off from University College London.

This work got preceded by David Baker and his colleagues, who have taken THREADER idea further in the form of the Rosetta method which has a huge impact in the field.

MEMSAT[7] is an approach to predict the positions of transmembrane helix segments based on the recognition of the topological models of proteins.

[citation needed] His research has been funded by the BBSRC, The Wellcome Trust, Elsevier, the EPSRC, the MRC, The Royal Society, The European Commission, AstraZeneca, GlaxoSmithKline and Sun Microsystems.